IMPORTANCE: Recanalization of intracranial thrombus is associated with improved clinical outcome in patients with acute ischemic stroke. The association of intravenous alteplase treatment and thrombus characteristics with recanalization over time is important for stroke triage and future trial design. OBJECTIVE: To examine recanalization over time across a range of intracranial thrombus occlusion sites and clinical and imaging characteristics in patients with ischemic stroke treated with intravenous alteplase or not treated with alteplase. DESIGN, SETTING, AND PARTICIPANTS: Multicenter prospective cohort study of 575 patients from 12 centers (in Canada, Spain, South Korea, the Czech Republic, and Turkey) with acute ischemic stroke and intracranial arterial occlusion demonstrated on computed tomographic angiography (CTA). EXPOSURES: Demographics, clinical characteristics, time from alteplase to recanalization, and intracranial thrombus characteristics (location and permeability) defined on CTA. MAIN OUTCOMES AND MEASURES: Recanalization on repeat CTA or on first angiographic acquisition of affected intracranial circulation obtained within 6 hours of baseline CTA, defined using the revised arterial occlusion scale (rAOL) (scores from 0 [primary occlusive lesion remains the same] to 3 [complete revascularization of primary occlusion]). RESULTS: Among 575 patients (median age, 72 years [IQR, 63-80]; 51.5% men; median time from patient last known well to baseline CTA of 114 minutes [IQR, 74-180]), 275 patients (47.8%) received intravenous alteplase only, 195 (33.9%) received intravenous alteplase plus endovascular thrombectomy, 48 (8.3%) received endovascular thrombectomy alone, and 57 (9.9%) received conservative treatment. Median time from baseline CTA to recanalization assessment was 158 minutes (IQR, 79-268); median time from intravenous alteplase start to recanalization assessment was 132.5 minutes (IQR, 62-238). Successful recanalization occurred at an unadjusted rate of 27.3% (157/575) overall, including in 30.4% (143/470) of patients who received intravenous alteplase and 13.3% (14/105) who did not (difference, 17.1% [95% CI, 10.2%-25.8%]). Among patients receiving alteplase, the following factors were associated with recanalization: time from treatment start to recanalization assessment (OR, 1.28 for every 30-minute increase in time [95% CI, 1.18-1.38]), more distal thrombus location, eg, distal M1 middle cerebral artery (39/84 [46.4%]) vs internal carotid artery (10/92 [10.9%]) (OR, 5.61 [95% CI, 2.38-13.26]), and higher residual flow (thrombus permeability) grade, eg, hairline streak (30/45 [66.7%]) vs none (91/377 [24.1%]) (OR, 7.03 [95% CI, 3.32-14.87]). CONCLUSIONS AND RELEVANCE: In patients with acute ischemic stroke, more distal thrombus location, greater thrombus permeability, and longer time to recanalization assessment were associated with recanalization of arterial occlusion after administration of intravenous alteplase; among patients who did not receive alteplase, rates of arterial recanalization were low. These findings may help inform treatment and triage decisions in patients with acute ischemic stroke.

Bezmialem Vakif Univesitesi Noroloji Istanbul Turkey

Gold Coast University Hospital Gold Coast Australia

Greenfield Park Québec Canada

Gwangju Institute of Science and Technology Gwangju Republic of Korea

IDI IDIBGI Dr Josep Trueta University Hospital Girona Spain

International Clinical Research Center Department of Neurology St Ann's University Hospital Masaryk University Brno Czech Republic

Keimyung University Daegu Republic of Korea

King Faisal Specialist Hospital and Research Center Riyadh Saudi Arabia

Queen's University Kingston Ontario Canada

Universidad de Valladolid Valladolid Spain

University of British Columbia Vancouver British Columbia Canada

University of Calgary Calgary Alberta Canada

University of Manitoba Winnipeg Manitoba Canada

University of Miami Miami Florida

University of Montreal Montreal Québec Canada

University of Ottawa Ottawa Ontario Canada

Zobrazit více v PubMed

National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333(24):1581-1587. doi:10.1056/NEJM199512143332401 PubMed DOI

Hacke W, Kaste M, Bluhmki E, et al. ; ECASS Investigators . Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008;359(13):1317-1329. doi:10.1056/NEJMoa0804656 PubMed DOI

Goyal M, Menon BK, van Zwam WH, et al. ; HERMES collaborators . Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet. 2016;387(10029):1723-1731. doi:10.1016/S0140-6736(16)00163-X PubMed DOI

Saver JL. Time is brain–quantified. Stroke. 2006;37(1):263-266. doi:10.1161/01.STR.0000196957.55928.ab PubMed DOI

Saver JL, Fonarow GC, Smith EE, et al. . Time to treatment with intravenous tissue plasminogen activator and outcome from acute ischemic stroke. JAMA. 2013;309(23):2480-2488. doi:10.1001/jama.2013.6959 PubMed DOI

Saver JL, Goyal M, van der Lugt A, et al. ; HERMES Collaborators . Time to treatment with endovascular thrombectomy and outcomes from ischemic stroke: a meta-analysis. JAMA. 2016;316(12):1279-1288. doi:10.1001/jama.2016.13647 PubMed DOI

Alexandrov AV, Burgin WS, Demchuk AM, El-Mitwalli A, Grotta JC. Speed of intracranial clot lysis with intravenous tissue plasminogen activator therapy: sonographic classification and short-term improvement. Circulation. 2001;103(24):2897-2902. doi:10.1161/01.CIR.103.24.2897 PubMed DOI

del Zoppo GJ, Poeck K, Pessin MS, et al. . Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke. Ann Neurol. 1992;32(1):78-86. doi:10.1002/ana.410320113 PubMed DOI

Molina CA, Montaner J, Abilleira S, et al. . Timing of spontaneous recanalization and risk of hemorrhagic transformation in acute cardioembolic stroke. Stroke. 2001;32(5):1079-1084. doi:10.1161/01.STR.32.5.1079 PubMed DOI

Ribo M, Alvarez-Sabín J, Montaner J, et al. . Temporal profile of recanalization after intravenous tissue plasminogen activator: selecting patients for rescue reperfusion techniques. Stroke. 2006;37(4):1000-1004. doi:10.1161/01.STR.0000206443.96112.d9 PubMed DOI

Labiche LA, Malkoff M, Alexandrov AV. Residual flow signals predict complete recanalization in stroke patients treated with TPA. J Neuroimaging. 2003;13(1):28-33. doi:10.1111/j.1552-6569.2003.tb00153.x PubMed DOI

Demchuk AM, Goyal M, Yeatts SD, et al. ; IMS III Investigators . Recanalization and clinical outcome of occlusion sites at baseline CT angiography in the Interventional Management of Stroke III trial. Radiology. 2014;273(1):202-210. doi:10.1148/radiol.14132649 PubMed DOI PMC

Goyal M, Demchuk AM, Menon BK, et al. ; ESCAPE Trial Investigators . Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med. 2015;372(11):1019-1030. doi:10.1056/NEJMoa1414905 PubMed DOI

Millán M, Remollo S, Quesada H, et al. ; REVASCAT Trial Investigators . Vessel patency at 24 hours and its relationship with clinical outcomes and infarct volume in REVASCAT Trial (Randomized Trial of Revascularization With Solitaire FR Device Versus Best Medical Therapy in the Treatment of Acute Stroke Due to Anterior Circulation Large Vessel Occlusion Presenting Within Eight Hours of Symptom Onset). Stroke. 2017;48(4):983-989. doi:10.1161/STROKEAHA.116.015455 PubMed DOI

Seners P, Turc G, Maïer B, Mas JL, Oppenheim C, Baron JC. Incidence and predictors of early recanalization after intravenous thrombolysis: a systematic review and meta-analysis. Stroke. 2016;47(9):2409-2412. doi:10.1161/STROKEAHA.116.014181 PubMed DOI

Goyal M, Menon BK, Krings T, et al. . What constitutes the M1 segment of the middle cerebral artery? J Neurointerv Surg. 2016. doi:10.1136/neurintsurg-2015-012191 PubMed DOI

Puetz V, Dzialowski I, Hill MD, et al. ; Calgary CTA Study Group . Intracranial thrombus extent predicts clinical outcome, final infarct size and hemorrhagic transformation in ischemic stroke: the clot burden score. Int J Stroke. 2008;3(4):230-236. doi:10.1111/j.1747-4949.2008.00221.x PubMed DOI

Mishra SM, Dykeman J, Sajobi TT, et al. . Early reperfusion rates with IV tPA are determined by CTA clot characteristics. AJNR Am J Neuroradiol. 2014;35(12):2265-2272. doi:10.3174/ajnr.A4048 PubMed DOI PMC

Khatri P, Neff J, Broderick JP, Khoury JC, Carrozzella J, Tomsick T; IMS-I Investigators . Revascularization end points in stroke interventional trials: recanalization versus reperfusion in IMS-I. Stroke. 2005;36(11):2400-2403. doi:10.1161/01.STR.0000185698.45720.58 PubMed DOI

Bhatia R, Hill MD, Shobha N, et al. . Low rates of acute recanalization with intravenous recombinant tissue plasminogen activator in ischemic stroke: real-world experience and a call for action. Stroke. 2010;41(10):2254-2258. doi:10.1161/STROKEAHA.110.592535 PubMed DOI

Zangerle A, Kiechl S, Spiegel M, et al. . Recanalization after thrombolysis in stroke patients: predictors and prognostic implications. Neurology. 2007;68(1):39-44. doi:10.1212/01.wnl.0000250341.38014.d2 PubMed DOI

Huang X, Moreton FC, Kalladka D, et al. . Coagulation and fibrinolytic activity of tenecteplase and alteplase in acute ischemic stroke. Stroke. 2015;46(12):3543-3546. doi:10.1161/STROKEAHA.115.011290 PubMed DOI

Kim YD, Nam HS, Kim SH, et al. . Time-dependent thrombus resolution after tissue-type plasminogen activator in patients with stroke and mice. Stroke. 2015;46(7):1877-1882. doi:10.1161/STROKEAHA.114.008247 PubMed DOI

Fuentes B, Alonso de Leciñana M, Ximénez-Carrillo A, et al. ; Madrid Stroke Network . Futile interhospital transfer for endovascular treatment in acute ischemic stroke: the Madrid Stroke Network Experience. Stroke. 2015;46(8):2156-2161. doi:10.1161/STROKEAHA.115.009282 PubMed DOI

Boulouis G, Siddiqui KA, Lauer A, et al. . Immediate vascular imaging needed for efficient triage of patients with acute ischemic stroke initially admitted to nonthrombectomy centers. Stroke. 2017;48(8):2297-2300. doi:10.1161/STROKEAHA.117.017607 PubMed DOI

Campbell BCV, Mitchell PJ, Churilov L, et al. ; EXTEND-IA TNK Investigators . Tenecteplase versus alteplase before thrombectomy for ischemic stroke. N Engl J Med. 2018;378(17):1573-1582. doi:10.1056/NEJMoa1716405 PubMed DOI

Barreto AD, Alexandrov AV, Lyden P, et al. . The argatroban and tissue-type plasminogen activator stroke study: final results of a pilot safety study. Stroke. 2012;43(3):770-775. doi:10.1161/STROKEAHA.111.625574 PubMed DOI PMC

Adeoye O, Sucharew H, Khoury J, et al. . Combined approach to lysis utilizing eptifibatide and recombinant tissue-type plasminogen activator in acute ischemic stroke-full dose regimen stroke trial. Stroke. 2015;46(9):2529-2533. doi:10.1161/STROKEAHA.115.010260 PubMed DOI PMC

Alexandrov AV, Molina CA, Grotta JC, et al. ; CLOTBUST Investigators . Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke. N Engl J Med. 2004;351(21):2170-2178. doi:10.1056/NEJMoa041175 PubMed DOI

Menon BK, d’Esterre CD, Qazi EM, et al. . Multiphase CT angiography: a new tool for the imaging triage of patients with acute ischemic stroke. Radiology. 2015;275(2):510-520. doi:10.1148/radiol.15142256 PubMed DOI

A collateral circulation in ischemic stroke accelerates recanalization due to lower clot compaction

Automated Segmentation of Intracranial Thrombus on NCCT and CTA in Patients with Acute Ischemic Stroke Using a Coarse-to-Fine Deep Learning Model

Development and Testing of Thrombolytics in Stroke

Thrombectomy vs medical management in low NIHSS acute anterior circulation stroke

Comparison of different methods of thrombus permeability measurement and impact on recanalization in the INTERRSeCT multinational multicenter prospective cohort study

Clot Burden Score and Early Ischemia Predict Intracranial Hemorrhage following Endovascular Therapy